Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
OptimizeRx (OPRX) Stock Price & Analysis
444 Followers
OPRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.92 - $16.65
Previous Close$9.96
Volume6.08K
Average Volume (3M)114.59K
Market Cap
$183.57M
Enterprise Value$210.30M
Total Cash (Recent Filing)$13.85M
Total Debt (Recent Filing)$36.82M
Price to Earnings (P/E)-12.3
Beta1.89
Next Earnings
May 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.81
Shares Outstanding18,152,478
10 Day Avg. Volume86,200
30 Day Avg. Volume114,595
Standard Deviation0.20
R-Squared0.07
Alpha0.00645
Financial Highlights & Ratios
Price to Book (P/B)2.21
Price to Sales (P/S)9.53
Price to Cash Flow (P/CF)33.20
P/FCF Ratio42.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.94
Enterprise Value/Gross Profit4.90
Enterprise Value/Ebitda-11.12
Forecast
1Y Price Target
$16.17Price Target Upside65.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
OptimizeRx News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalysts predict strong revenue growth for OptimizeRx, with significant increases in adjusted EBITDA estimates for the coming years.
Market ValuationOptimizeRx's current stock valuation represents a discount to its two-year average and its biopharma technology peers, suggesting a compelling entry point for investors.
Strategic DevelopmentsThe acquisition of Medicx should meaningfully increase OptimizeRx's growth opportunity by adding a direct-to-consumer marketing platform.
Bears Say
Accounting ChangesOptimizeRx's shift in treatment of certain Medicx revenue to net, from gross, is not ideal.
Financial PerformanceOperational cash burn was reported, indicating a potential area of concern.
Revenue GuidanceOptimizeRx lowered its revenue guidance for the following year to 'at least $100M,' from a previous 'at least $110M.'
---
Ownership Overview
51.17% Insiders
18.46% Mutual Funds
9.33% Other Institutional Investors
21.05% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OPRX FAQ
What was OptimizeRx Corporation’s price range in the past 12 months?
OptimizeRx Corporation lowest stock price was $6.92 and its highest was $16.64 in the past 12 months.
What is OptimizeRx Corporation’s market cap?
Currently, no data Available
When is OptimizeRx Corporation’s upcoming earnings report date?
OptimizeRx Corporation’s upcoming earnings report date is May 08, 2024 which is in 15 days.
How were OptimizeRx Corporation’s earnings last quarter?
OptimizeRx Corporation released its earnings results on Apr 16, 2024. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of -$0.119 by $0.429.
Is OptimizeRx Corporation overvalued?
According to Wall Street analysts OptimizeRx Corporation’s price is currently Undervalued.
Does OptimizeRx Corporation pay dividends?
OptimizeRx Corporation does not currently pay dividends.
What is OptimizeRx Corporation’s EPS estimate?
OptimizeRx Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OptimizeRx Corporation have?
OptimizeRx Corporation has 18,152,477 shares outstanding.
What happened to OptimizeRx Corporation’s price movement after its last earnings report?
OptimizeRx Corporation reported an EPS of $0.31 in its last earnings report, beating expectations of -$0.119. Following the earnings report the stock price went down -3.488%.
Which hedge fund is a major shareholder of OptimizeRx Corporation?
Among the largest hedge funds holding OptimizeRx Corporation’s share is S Squared Technology, LLC. It holds OptimizeRx Corporation’s shares valued at N/A.
---
OptimizeRx Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.17 (65.68% Upside)
$16.17 (65.68% Upside)
Blogger Sentiment
Bullish
OPRX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 17.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 3.4%
Last 30 Days ▼ 3.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.88%
12-Months-Change
Fundamentals
Return on Equity
-13.90%
Trailing 12-Months
Asset Growth
36.18%
Trailing 12-Months
Company Description
OptimizeRx Corporation
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.
---
OPRX Earnings Call
Q4 2024
0:00 / 0:00
---
OPRX Stock 12 Months Forecast
Average Price Target
$16.17
▲(65.68% Upside)
Technical Analysis
Best Analysts Covering OPRX
1 Year
1 Year Success Rate
6/11 ratings generated profit
1 Year Average Return
+72.85%
reiterated a buy rating 8 days ago
Copying Eric Martinuzzi's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +72.85% per trade.
---